Literature DB >> 3881156

Fulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection.

P Poldre, W Pruzanski, H M Chiu, D A Dotten.   

Abstract

Fulminant gangrene of the fingers, toes and nose developed in a 57-year-old woman with Escherichia coli pneumonia. Cryoglobulinemia was noted, and the cryoglobulin was identified as IgM-IgG with anti-I cold agglutinin activity. The cold agglutinins possessed potent lymphocytotoxic and monocytotoxic activity and weaker granulocytotoxic activity. Treatment with plasmapheresis, steroids and antibiotics led to complete clinical recovery, although amputation of several toes was necessary. The patient died 1 1/2 years later; the main findings at autopsy were chronic and acute pyelonephritis and acute bacterial endocarditis. This seems to be the first case of IgM-IgG cold agglutinemia occurring during the course of E. coli infection and the third case of fulminant gangrene complicating transient cold agglutinemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881156      PMCID: PMC1346707     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  20 in total

1.  Symmetrical peripheral gangrene in acquired hemolytic anemia.

Authors:  S KUMAR; M M SINGH; B B BHATIA; V S MANGALIK
Journal:  Acta Haematol       Date:  1958-06       Impact factor: 2.195

2.  [Paroxysmal hemoglobinuria with Raynaud's disease and left hand gangrene due to cryoagglutinemia with high titer in a patient with angiospastic crises due to a vibrating instrument].

Authors:  E ARRIGONI MARTELLI; G SAITA
Journal:  Med Lav       Date:  1956-11       Impact factor: 1.275

3.  The syndrome of high-titre cold haemagglutination; a survey and a case report.

Authors:  K RØRVIK
Journal:  Acta Med Scand       Date:  1954

4.  The syndrome of high-titre cold haemagglutination.

Authors:  M G NELSON; R J MARSHALL
Journal:  Br Med J       Date:  1953-08-08

5.  The influence of homogeneous cold agglutinins on human B and T lymphocytes.

Authors:  W Pruzanski; N Farid; E Keystone; M Armstrong; M F Greaves
Journal:  Clin Immunol Immunopathol       Date:  1975-07

6.  The influence of homogeneous cold agglutinins on polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; N Faird; E Keystone; M Armstrong
Journal:  Clin Immunol Immunopathol       Date:  1975-07

7.  Protein abnormalities in the cold haemagglutinin syndrome.

Authors:  M Harboe; H Torsvik
Journal:  Scand J Haematol       Date:  1969

Review 8.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Cold agglutinin disease in a patient with Legionnaires' disease.

Authors:  J W King; J S May
Journal:  Arch Intern Med       Date:  1980-11

10.  Raynaud's syndrome associated with idiopathic cryoglobulinemia and cold agglutinins; report of a case and discussion of classification of cryoglobulinemia.

Authors:  C G GADDY; L W POWELL
Journal:  AMA Arch Intern Med       Date:  1958-09
View more
  4 in total

Review 1.  The kidney in mixed cryoglobulinemias.

Authors:  D J Cordonnier; J C Renversez; P Vialtel; E Dechelette
Journal:  Springer Semin Immunopathol       Date:  1987

Review 2.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 3.  A case report of severe nasal ischemia from cold agglutinin disease and a novel treatment protocol including HBOT.

Authors:  Scott Kohlert; Laurie McLean; Dimitrios Scarvelis; Calvin Thompson
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-10-22

4.  A Case of Idiopathic Cold Agglutinin Hemolytic Anemia Successfully Treated With Steroids.

Authors:  Asim Haider; Fareeha Alavi; Ayesha Siddiqa; Muhammad Owais; Muzammil Khan
Journal:  Cureus       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.